Healthcare Business Review
About UsConferencePartner With Us
  • Patient Care
    Healthcare Concierge
    Medical Transportation
    Occupational Care
    Psychological Services
    Radiology
    Therapy Services
  • Operations
    Healthcare Marketing
    Healthcare Staffing
    Healthcare Tech
  • Healthcare Services
    Consulting Service
    Facility Management Services
    Healthcare Education
  • Leadership Perspectives
  • Insights
  • Research
  • News
  • Magazines
    • Europe
      • US
      • EUROPE
      • APAC
      • CANADA
      • LATAM

Healthcare Market Research Firms in Europe

Ipsos [EPA: IPS] has been recognized by Healthcare Business Review Magazine as the exclusive recipient of “Top Healthcare Market Research Firm In Europe 2026,” based on our proprietary methodology, reflecting its position in the industry, and is also named among “Top Healthcare Marketing Companies in Europe,” reflecting its broader leadership. This profile has been developed by the Healthcare Business Review research and editorial team based on insights from an interview with Kelly Beaver, CEO.

Ipsos [EPA: IPS]
Turning Healthcare Insights into Actionable Evidence

Ipsos [EPA: IPS]

Healthcare decisions require more than data. They need a clear understanding of patients, healthcare professionals, payers, markets and the factors shaping behaviour.

Ipsos [EPA: IPS] brings these perspectives together through specialist healthcare research, combining stakeholder insights and evidence to help clients make informed decisions across the product lifecycle. Its custom healthcare teams operate in more than 30 countries and draw on global healthcare frameworks, 13 Centres of Expertise and dedicated data science support. That structure allows research to start with the business question and align the right methods and expertise with the decision at hand.

The work spans the healthcare product lifecycle, from early asset strategy through launch and performance assessment. Commercial strategy research can examine market structure, patient journeys, unmet needs and potential opportunities, while launch work considers readiness and stakeholder response. This gives clients a way to move from a broad question about a market toward evidence that can support specific choices about development, positioning or commercialisation.

Method selection is equally central. Ipsos combines qualitative and quantitative research rather than treating either as the default. Its healthcare qualitative practice uses more than 30 research products alongside therapy-area knowledge. Quantitative approaches support areas like market sizing, treatment mapping and awareness measurement. This creates a research model that first uncovers the reasons behind stakeholder behaviour and then validates those insights by measuring their scale and patterns.

This combination is important when a healthcare question cannot be answered from one data source. The multi-source approach of Ipsos can bring together primary research, real-world evidence, client transactions, social listening and proprietary datasets. Data science and advanced analytics teams can then use those inputs for predictive models or targeting work, helping clients connect different forms of evidence instead of viewing each research stream in isolation.

Connecting Stakeholder Perspectives to Evidence

Healthcare decisions often depend on numerous groups whose priorities differ. Ipsos’ research network is designed to reach physicians, patients, payers and other healthcare professionals, supported by local teams and specialist fieldwork capabilities. Its multi-stakeholder access model can be used when a client needs respondent recruitment and data collection without a full-service research program, giving the design flexibility around the question being asked.

The patient research practice adds another layer by following people across the disease journey. Ipsos uses approaches that include ethnographic observation, online communities, qualitative interviews and quantitative studies to examine treatment pathways, perceptions and patient-reported outcomes. Rather than reducing the patient perspective to a single survey response, it can capture both lived experience and measurable patterns that inform patient-focused decisions.

Syndicated research provides a different route to evidence. Ipsos’ Global Therapy Monitors provide insights into real-world prescribing and healthcare professional perceptions, while its Global Oncology Monitor provides treatment data across tumour types. At the same time, disease experts tailor analyses to the client’s question. A company can use these datasets to size a market, examine prescribing behaviour or compare stakeholder perceptions without commissioning an entirely new primary study for every decision.

Market access and health economics research extend the stakeholder picture toward payer and value questions. Ipsos combines payer insight, economic modelling and syndicated real-world evidence within its market access and health economics and outcomes research practice. This allows research to move beyond preference measurement and examine how evidence may support access, value communication or reimbursement-related decisions, while remaining connected to the wider healthcare research program.

Behavioural Science Adds Explanatory Depth

Ipsos applies behavioural science when reported attitudes alone do not explain a decision. Its healthcare behavioural science team examines influences that may sit beneath self-reported responses, using psychology-informed methods to study how people think, feel and behave. The approach is relevant when researchers need to understand the drivers or barriers behind actions rather than simply record what respondents say they intend to do.

The workflow begins before fieldwork. Behavioural science constructs can inform the research question, and respondent profiling can use established academic tools. At the same time, study design can probe mental processes that standard questioning may miss. Analysis then applies behavioural theory to identify biases, drivers and barriers. Ipsos uses its proprietary MAPPS framework to organise the influences shaping behaviour, supporting a more structured understanding of the factors influencing decisions.

That capability can be applied to communication research, segmentation or product innovation. For example, a healthcare team evaluating a message can examine the behavioural influences that shape response. In a segmentation study, behavioural perspectives can help distinguish groups by the factors guiding action rather than relying only on demographic or attitudinal categories.

Qualitative observation strengthens this work by placing people back into context. Ipsos’ qualitative teams use immersive and observational methods to help clients understand healthcare professionals and patients as people making decisions within real environments. The company can combine those findings with quantitative research and other data sources, creating a path from close observation to evidence.

Disease Expertise Gives Research Its Context

Healthcare research gains value when methodology is paired with knowledge of the disease area being studied. Ipsos maintains dedicated Centres of Expertise in oncology, autoimmune disease, virology and vaccines, respiratory care, diabetes and rare diseases. These specialist groups bring accumulated market research knowledge, resources and real-world evidence into projects so that a study can reflect the treatment landscape surrounding the client’s question.

Oncology illustrates how that model works. Ipsos combines dedicated custom and syndicated teams with its Global Oncology Monitor, a database covering anti-cancer drug treatment across tumour types. It also connects oncology research to market access, advisory services and product-lifecycle work.

Rare-disease research applies the same specialist approach to areas where patient populations are small, and evidence gaps can be significant. Ipsos combines custom research, real-world evidence and advisory services to build a more informed view of these complex disease areas. Its Global Therapy Monitors, syndicated, ongoing healthcare datasets, compare healthcare professional awareness and perceptions with prescribing behaviour. This gives clients another way to connect stated views with evidence of what happens in practice.

Ipsos’ recognition as the Top Healthcare Market Research Firm in Europe 2026 reflects the depth and specialisation of its healthcare research capabilities. Its distinction rests on the way specialist healthcare teams combine qualitative and quantitative methods, stakeholder access, behavioural science, multi-source evidence and disease expertise to turn fragmented information into a decision-ready context for healthcare clients.

Healthcare Market Research Firms in Europe Info

Q1

What Do Healthcare Market Research Firms Typically Cover?

Healthcare Market Research Firms examine the factors shaping healthcare decisions across markets, products and stakeholder groups. Their work can include market structure, patient journeys, unmet needs, treatment mapping, awareness measurement and prescribing behavior. It can also help clarify how perceptions, access conditions and behavior influence a product or service at different stages. The goal is to turn scattered information into evidence that can support decisions throughout a healthcare product lifecycle.

Q2

How Does Ipsos Apply Healthcare Market Research Firms Capabilities Across the Product Lifecycle?

Ipsos applies Healthcare Market Research Firms capabilities from early asset strategy through launch and performance assessment. Its custom healthcare teams operate in more than 30 countries, supported by 13 Centres of Expertise and dedicated data science resources. Its work can connect market questions with research methods suited to development, positioning and commercialization decisions. This structure allows research programs to begin with a defined business question and align methods and specialist knowledge with the decision being considered.

Q3

Which Research Methods Matter When Healthcare Questions Are Complex?

Healthcare Market Research Firms can combine qualitative and quantitative methods when one approach cannot provide enough context. Qualitative work can explore why patients or healthcare professionals behave in particular ways, while quantitative research can measure the scale of those patterns. Multi-source programs may also bring together primary research, real-world evidence, social listening, client transactions and proprietary datasets. Data science and advanced analytics can then help connect those inputs, including through predictive models or targeting work where appropriate.

Q4

How Can Healthcare Market Research Firms Bring Patient and Stakeholder Perspectives Together?

Healthcare Market Research Firms can examine physicians, patients, payers and other healthcare professionals through research designs suited to different perspectives. Patient research may use ethnographic observation, online communities, interviews and quantitative studies to examine treatment pathways and patient-reported outcomes. This broader view helps connect lived experience with measurable evidence. Stakeholder access and local fieldwork capabilities can also support respondent recruitment and data collection when a project requires focused research rather than a full-service program.

Q5

What Distinguishes Ipsos in Healthcare Market Research Firms Work?

Ipsos combines stakeholder access, behavioral science, disease expertise and multiple evidence sources within its healthcare research model. Its specialist Centres of Expertise cover areas including oncology, autoimmune disease, virology and vaccines, respiratory care, diabetes and rare diseases. Its Global Therapy Monitors and Global Oncology Monitor add syndicated evidence on prescribing, perceptions and treatment patterns. Ipsos also uses its proprietary MAPPS framework within behavioral science work to examine influences, drivers and barriers behind healthcare decisions.

Q6

How Should Organizations Evaluate Healthcare Market Research Firms for Decision Support?

Healthcare Market Research Firms should be evaluated on whether their methods fit the question, evidence can be connected across sources and findings provide useful context for decisions. Relevant considerations include stakeholder access, methodological breadth, disease-area knowledge, analytical capability and the ability to move from observation to measurable evidence. A well-matched research program can make complex healthcare information more usable without reducing important differences between perspectives. The strongest fit depends on the research objective, evidence requirements and stage of the healthcare product or decision being examined.

Top Healthcare Market Research Firm In Europe 2026

Company :Ipsos [EPA: IPS]

Management

Kelly Beaver, CEO

Thank you for Subscribing to Healthcare Business Review Weekly Brief

Healthcare Business Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editorial@healthcarebusinessreview.com
  • salesus@healthcarebusinessreview.com
  • marketingus@healthcarebusinessreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Healthcare Business Review Europe. All rights reserved.

CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.healthcarebusinessrevieweurope.com/ipsos-2026